baber/WOPTO huggingface dataset:
Patent FI-945583-A0 (FI)
Inventor: EASTON DAVID JOSEPH
IPC: F16H59/12
Filed: 1994-11-28
Abstract: The control lever assembly for generating control signals for a power-shift transmission, has a housing, to which a lever is pivotally coupled. A lever guide has a slot which slidably receives the lever and limits it to move within a defined path, and signal generators output signals representing the positions of the lever within the slot. A main slot extends in a first direction, and a first sub-slot is spaced apart from it and extends parallel to the first direction. A second sub-slot is spaced apart from the main slot and extends parallel to the first direction. A third sub-slot is spaced apart from the main slot and extends parallel to the first direction, and each sub-slot is connected with the main slot by a corresp. connecting slot extending transverse to the first direction.   The first and second connecting slots open into a central portion of the corresp. sub-slots, and the third connecting slot opens into an end of the third sub-slot, which extends from the end towards the two sub-slots. The sub-slots are arranged in an array which is parallel to the main slot. Each sub-slot has a length which is shorter than that of the main slot.
Patent FI-980819-A0 (FI)
Inventor: MYLLYMAEKI MATTI
IPC: G08B21/04
Filed: 1998-04-09
Abstract: An automatic control system for actuators and security devices in building automation. A wrist-held sensor and transmitter unit (11) transmits repeatedly, in the form of short telegrams, messages indicating the physiological condition of user to a receiver and control apparatus (12), which is placed in a monitored space either as a separate unit or a part of an appliance to be controlled. The receiver and control apparatus (12), or an information analyzer in data transfer communication therewith, uses the physiological condition of a user as a basis to conduct control selections and to control automatically the actuators and security devices in accordance with the physiological condition of a person who carries the transmitter unit (11). If necessary, the control selections can be influenced also by a piece of information indicating the location of a user. In addition to the automatic control of nearby equipment, the system is also applicable to monitoring the health of a user and to setting off alarms.
Patent FI-980945-A0 (FI)
Inventor: SAVOLAINEN JOUKO
IPC: A23J3/08
Filed: 1998-04-29
Abstract: A method for modification and isolation of a protein is provided. The method includes the steps of providing a protein selected from the group consisting of whey and soy proteins; providing a reagent that forms sulfite ions; mixing the protein with the reagent under a condition to sulfonate the protein without using an oxidizing agent and to obtain a mixture containing a sulfonated protein; precipitating the sulfonated protein out of the mixture at an acid pH to form a precipitated sulfonated protein and a soluble sulfonated protein; and recovering the precipitated sulfonated protein or soluble sulfonated protein.
Patent FI-982272-A0 (FI)
Inventor: KIRJAVAINEN KARI
IPC: B29C48/49
Filed: 1998-10-21
Abstract: An extrusion method and an extruder, the material to be extruded being fed with a material feeding device (1) into a radial pump unit included in the equipment. The radial pump unit comprises conical gearwheels (2) which are adjacently positioned and rotate in opposite directions. The radial pump unit transfers the material in an annular flow into the extruder's nozzle (4). Additional material (20) can be supplied into the product through the radial pump unit.
Patent IL-73423-A0 (IL)
Title: Low loss cladded optical fibers from halides and process for making same
IPC: B29C48/475
Filed: 1984-11-05
Abstract: Cladded halide optical fibres for infrared transmission are made by covering a two-part halide compound billet (15), comprising a core (10), and a sleeve (8), with a polymer layer (12), heating the assembly and drawing it through a die (14). The halide compound forming the sleeve (8) has a lower refractory index than the halide compound forming the billet core (10). A second polymer layer (31) can be provided between the respective halide compounds.
Patent IL-75707-A0 (IL)
Title: Method and suspension medium for preserving red blood cells
IPC: A61K35/18
Filed: 1985-07-03
Abstract: The present invention discloses a hypotonic suspension medium and a method for prolonged storage of red blood cells at about 4 DEG  C. The suspension medium comprises about 80-150 mM glucose, 30-80 mM mannitol, 6-90 mM potassium citrate, 1-5 mM adenine and 10-200 mM ammonium chloride or acetate in an aqueous solution having a pH of about 6.8 to 7.2 and an osmolarity of about 180-220 milli-osmolar. The suspension medium and the method of the present invention allow viable storage of red blood cells at about 4 DEG  C. up to 125 days or more.
Patent IL-81281-A0 (IL)
Title: Pharmaceutical sustained release compositions
IPC: A61K9/26
Filed: 1987-01-16
Abstract: Prepn. of compsn. comprising a compressed mixt. of a pharmacologically active ingredient (I) and 7.5-28 wt.% of the compsn. of a sustained release carrier (II) comprising a major proportion of xanthan gum comprises mixing (I) with (II) and compressing the mixt. to produce a solid formulation. Pref. (II) comprises at least 90 wt.% xanthan gum. Pref. the ratio of (II) to (I) is 1:10 to 1:1.
Patent IL-90267-A0 (IL)
Title: Enantiomeric glutaramide diuretic agents
IPC: A61P9/00
Filed: 1989-05-11
Abstract: S Enantiomeric diuretic agent of the formula: <CHEM> wherein each R and R<4> is H or one of R and R<4> is H and the other is a biolabile ester group, a process for their preparation and intermediates therefor.
Patent IL-95444-A0 (IL)
Title: (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents,their preparation and pharmaceutical compositions containing them
IPC: C07D215/14
Filed: 1990-08-21
Abstract: Cyclically substituted (quinolin-2-ylmethoxy)phenylacetic acid derivatives can be prepared by reaction of corresponding CH acidic compounds with open-chain dihalogen compounds. The cyclically substituted (quinolin-2-ylmethoxy)phenylacetic acid derivatives can be employed as active substances in medicaments.
Patent IL-96326-A0 (IL)
Title: Polymyxin conjugates,their preparation and pharmaceutical compositions containing them
IPC: A61K38/00
Filed: 1990-11-13
Abstract: Water-soluble polymyxin-carrier conjugates such as polymyxin B-dextran conjugates are disclosed. They have a greater half-life in the bloodstream and are significantly more potent and less toxic than native polymyxins.
Patent IL-99168-A0 (IL)
Title: 1-(pyridinylalkyl-1h-indoles,indolines and related analogs
IPC: C07D401/06
Filed: 1991-08-12
Abstract: This invention relates to compounds of the formula <CHEM>  wherein   R1   is hydrogen, loweralkyl, arylloweralkyl, loweralkenyl or loweralkynyl; R2   is hydrogen, lowralkyl, loweralkenyl, formyl or cyano; X   is hydrogen, halogen, nitro, amino, loweralkyl, loweralkoxy or hydroxy; Y   is hydrogen, loweralkyl, loweralkoxy, arylloweralkoxy, hydroxy, halogen, nitro or amino; the pharmaceutically acceptable acid addition salts thereof, and, where applicable, the geometric and optical isomers and racemic mixtures thereof. The compounds of the invention are useful for the treatment of various memory dysfunctions characterized by a decreased cholinergic function, such as Alzheimer's disease.
Patent FI-20000548-A0 (FI)
Inventor: HYYTIAEINEN JOUKO
IPC: F16D11/14
Filed: 2000-03-10
Abstract: The present invention relates to a locking system for a rotating joint. In the device, the locking system (L) comprises a rigid locking means (12) movable in the axial direction (X1), provided with a first cogging (13) which can be moved for locking with the locking means (12) in a contact with a second cogging (14), to transmit the rotational movement, wherein said coggings (13, 14) are, for releasing the cogging, designed in such a way that a force effect releasing the locking is formed between them, and a third cogging (16) which is, during the locking, in a contact with a fourth cogging, to transmit the rotational motion, as well as a sealing element (21) for forming at least one closed hydraulic space (24) with a varying volume between the locking means (12) and the sealing element (21), wherein the locking means (12) is arranged to be moved for the locking and to be kept in the locking by the effect of a pressurized medium.
Patent IL-103558-A0 (IL)
Title: Tri-substituted tetrahydrofuran antifungals
IPC: C07D249/08
Filed: 1992-10-27
Abstract: An antifungal compound represented by formula ÄIÜ: <CHEM> wherein X is independently both F or both Cl or one X is F and the other is Cl;   Y= <CHEM>   R'   = (C<5>-C<5><4>) alkyl; (C<6>-C<5><4>)alkenyl; (C<6>-C<5><4>)alkynyl; (C<7>-C3/4 )cycloalky or CH<6>R<2>; R<2>   = (C<5>-C<7>)perhaloalkyl; CO<6>R<3> *CH(OR4)CH<6>OR4 or CH<6>N(R5) R<3>   = lower alkyl or H R4   = R<3> or (CH<6>)<6>OR<3> R5   = lower alkyl Z=H, or (C<5>-C psi ) alkanoyl and the carbons with the asterisks (*) have the R or S absolute configuration; or a pharmaceutically acceptable salt thereof as well as pharmacetical compositions containing them and a methods of treating or preventing fungal infections in mammals using them are disclosed.
Patent IL-107200-A0 (IL)
Title: Process for the production of an alkali metal citrate
IPC: C07C51/487
Filed: 1993-10-06
Abstract: A process for obtaining an alkali metal citrate from an aqueous solution eg., a fermentation broth, comprises adjusting the pH to more than 5.4, preferably to about 8.5, contacting the solution with a polymeric adsorbent eg. a weakly basic anion exchange resin, eluting the charged adsorbent with a solution of an alkali metal hydroxide or salt and recovering the aqueous solution of the alkali metal citrate.
Patent IL-109534-A0 (IL)
Title: Pour-on formulations containing polymeric material, glycols and glycerides and a process for their preparation
IPC: A01N25/02
Filed: 1994-05-03
Abstract: There is disclosed a topical formulation containing glycols, glycerides, or their derivatives, an avermectin compound (active ingredient) and optionally a polymeric material which has been discovered to provide superior efficacy against endoparasites and ectoparasites when compared to conventional formulations and to maintain the concentration of the active compound in the milk of dairy animals below a safe concentration for human consumption. The formulation contains the avermectin active ingredient and at least 50 % of the glycol or glyceride or polymeric material.
Patent IL-113021-A0 (IL)
Title: A sterile pharmaceutical composition comprising an oil-in-water emulsion
IPC: A61K9/113
Filed: 1995-03-17
Abstract: Sterile pharmaceutical compsn. for parenteral admin. is an oil-in-water emulsion in which propofol (I) (2,6-diisopropylphenol), opt. dissolved in a water-immiscible solvent, is emulsified with water and stabilised by surfactant. It also includes enough EDTA or salt to prevent growth of microorganisms for at least 24 hr after accidental contamination. Also new are similar emulsions that do not contain (I) but may contain some other therapeutic or pharmaceutical agent (II), opt. dissolved in organic solvent.
Patent IL-125277-A0 (IL)
Title: Switch status sensor
IPC: H01H35/40
Filed: 1997-01-09
Abstract: A switch status sensor is provided for counting on/off events of a switch of a water meter. When an on/off event is detected by a microcontroller, the microcontroller supplies a "signature" signal, which is distinguishable from electromagnetic noise, to the switch. If this "signature" signal is detected as having passed through the switch by the microcontroller, then it can be confirmed that the switch is closed. Alternatively, if the "signature" signal is not detected as having passed through the switch by the microcontroller, then it is verified that the switch is open. Thus, the switch status sensor can distinguish between false switch events caused by electromagnetic noise and true on/off events of the switch.
Patent IL-126366-A0 (IL)
Title: Photopheresis treatment of leukocytes
IPC: A61K31/365
Filed: 1997-03-26
Abstract: A method of treating infections of mononuclear blood cells, other than retroviral infections, is disclosed. A method of modulating the function of monocytes is also disclosed. The method involves the treatment of a patient's blood with a photoactivatable compound followed by ultra violet light-activation of the photoactivatable compound. The blood treated as such is returned to the patient in a process known as extracorporeal photopheresis. Monocyte function is modulated by this treatment.
Patent IL-130614-A0 (IL)
Title: Aqueous preparations and their use
IPC: C08L37/00
Filed: 1997-12-19
Abstract: Aqueous preparations comprisinga) from 0.1 to 10% by weight of a copolymer based on N-vinylcaprolactam, N-vinylpyrrolidone and N-vinylimidazole andb) from 0.1 to 10% by weight of at least one polyoxyethylene C6-C15-monoalkyl ether,and their use in cosmetic formulations are described.
Patent IL-132239-A0 (IL)
Title: Humanized antibodies and methods for forming humanized antibodies
IPC: C07K16/18
Filed: 1998-04-03
Abstract: Humanized and variant anti-VEGF antibodies and various uses therefore are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells  in vitro,  and inhibit tumor growth  in vivo.
Patent IL-133106-A0 (IL)
Title: A method for producing a porous carbon article and an article produced thereby
IPC: H01G9/00
Filed: 1998-05-29
Abstract: A workpiece with transport porosity is formed. Nanopores are formed in the workpiece by a thermochemical treatment. The workpiece is formed as a rigid carbonaceous skeleton containing in its structure particles of one or more carbides, being selected and arranged in order to provide predetermined nanopore sizes, a predetermined volume of nanopores and a predetermined distribution of nanopores within the volume of the article dependent on its intended use.
Patent IL-145076-A0 (IL)
Title: Novel intermediate for the synthesis of prostaglandins
IPC: C07F7/18
Filed: 2000-04-11
Abstract: An enantiomerically enriched compound of formula (1), wherein Ar is phenyl optionally substituted with one or more groups selected from haloalkyl, alkyl and halide. This compound can be isolated in crystalline form, and used in the preparation of (+)-16-[3-trifluoromethyl)phenoxy]-17, 18, 19, 20-tetranor PGF2 alpha  isopropyl ester.
Patent IL-152998-A0 (IL)
Title: Polysulfonamide matrices
IPC: C22B3/22
Filed: 2001-05-23
Abstract: Semi-permeable membranes are described that allow for the efficient processing of many liquid based feed solutions, particularly those that contain acids. The membranes of this invention are able to process such feeds with high permeate rates while maintaining excellent retention of dissolved metals, cations, and organic compounds, even in the presence of hot concentrated acids. The semi-permeable membranes of this invention are able to conduct such separations for a useful period of time due to their chemical stability towards acids and their ability to permeate acids.
Patent IL-154882-A0 (IL)
Title: Method and system for detection of cardiac arrhythmia
IPC: A61N1/39
Filed: 2001-09-20
Abstract: There are many different serious cardiac arrhythmias. The present invention uses measurements of RR intervals (interbeat intervals) to detect, in particular but not exclusively, atrial fibrillation of a patient. Atrial fibrilation is a serious ailment in which the heartbeat is generally rapid and irregular. Probability density histograms of DeltaRRs (difference between two successive RR intervals) collected during atrial fibrillation of a plurality of subjects are used as a template for the detection of atrial fibrillation. In one implementation, there are 16 standard probability density DeltaRRs histograms every 50 ms of mean RR interval of a certain number of beats, where the mean RR interval ranges from 350 ms to 1149 ms. Similarity between the standard probability density histograms and a test density probability histogram of DeltaRRs of a patient is estimated by the Kolmogorov-Smirnov test. If the test density histogram is not significantly different from the standard density histogram, atrial fibrillation is detected.
Patent IL-155514-A0 (IL)
Title: Fusion cells and cytokine compositions for treatment of disease
IPC: A61P31/18
Filed: 2001-10-22
Abstract: The present invention relates to methods and compositions for treating and preventing cancer and infectious disease by administering a therapeutically effective dose of fusion cells formed by fusion of autologous dendritic cells and autologous non-dendritic cells, in combination with a cytokine or other molecule which stimulates or induces a cytotoxic T cell response and/or a humoral immune response.
Patent IL-166330-A0 (IL)
Title: Label film for in-mould methods
IPC: B32B27/18
Filed: 2005-01-17
Abstract: Biaxially oriented opaque polypropylene laminated film (I), with a density of 0.4-0.7 g/cm3, has (A) a base layer with a density of 0.35-0.6 g/cm3, which contains vacuoles but no additives of density higher than that of the polypropylene; (B) intermediate layer(s) with no vacuoles; and (C) top layer(s) containing not less than 80 wt.% copolymer of 1.2 to under 2.8 wt.% ethylene and 97.2-98.8 wt.% propylene. Biaxially oriented opaque polypropylene laminated film (I), with a density of 0.4-0.7 g/cm3, has (A) a base layer with a density of 0.35-0.6 g/cm3, which contains vacuoles but no additives of density higher than that of the polypropylene; (B) intermediate layer(s) with no vacuoles; and (C) top layer(s) containing not less than 80 wt.% copolymer of 1.2 to under 2.8 wt.% ethylene and 97.2-98.8 wt.% propylene with melting point 145-160degreesC and melt enthalpy 80-110 J/g. An Independent claim is also included for laminated film (II), which is the same as (I) except that it has a density of 0.45-0.95 g/cm3 and the base layer has a density of 0.4-0.9 g/cm3 and contains titanium dioxide (TiO2).
Patent IL-173495-A0 (IL)
Title: Cooling machine which functions according to the stirling cycle
Filed: 2006-02-02
Abstract: The machine has a compressor comprising a compression piston (6) which is moved in a compression cylinder. The piston has a crank (12) with a variable length during the rotation of a crankshaft (11) so that the movement of the piston is slowed down during its passage from top dead center and bottom dead center. The crank is formed of crank sections (12a, 12b) which are articulated with each other.
Patent IL-173698-A0 (IL)
Title: Reduced calorie or non-caloric frozen non-carbonated beverage containing freezing point depressants
IPC: A23L2/54
Filed: 2006-02-13
Abstract: The present invention is a non-caloric or reduced calorie frozen carbonated beverage and a method of making it. The freezing point of a diet beverage syrup is reduced through the use of a freezing point depressant, particularly a Sugar MNS which is used to replace a portion of the known high-potency non-caloric sweetener. The preferred Sugar MNS for use in the beverage and method of the present invention is erythritol.
Patent IL-176522-A0 (IL)
Title: Universal amplification of fragmented rna
IPC: C12P19/34
Filed: 2006-06-22
Abstract: The invention relates to methods of using fragmented RNA, such as RNA obtained from archived fixed paraffin-embedded tissue material (FPET RNA) or other clinically biopsied tissue specimens for universal gene expression profiling.
Patent IL-183807-A0 (IL)
Title: Piperidinesulfonylureas and-thioureas, their preparation, their use and pharmaceutical compositions comprising them
Filed: 2007-06-10
Abstract: The present invention relates to piperidinesulfonylureas and piperidinesulfonylthioureas of formula I, in which A, X, R(1), R(2) and R(3) have the meanings indicated in the claims. The compounds of formula I are valuable active pharmaceutical ingredients which show in particular an inhibiting effect on ATP-sensitive potassium channels of the cardiac muscle and are suitable, for example, for the treatment of disorders of the cardiovascular system such as coronary heart disease, arrhythmias, cardiac insufficiency, cardiomyopathies or reduced contractility of the heart or for the prevention of sudden cardiac death. The invention further relates to processes for preparing the compounds of formula I, their use and pharmaceutical compositions comprising them.
Patent IL-193182-A0 (IL)
Title: Data mining by determining patterns in input data
Filed: 2008-07-31
Abstract: Patterns detection to input data containing a plurality of transactions, each transaction having at least one item, is carried out in the following way. Filter conditions for interesting patterns are received, and a first wet of filter conditions applicable in connection with generation of candidate patterns is determined.
Patent IL-200410-A0 (IL)
Title: Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
Filed: 2009-08-13
Abstract: Derivatives of psammaplin A of formula (I), a method for their synthesis and their use for the preparation of a medicament for preventing and /or treating a tumor or a cancer.
Patent ZW-4785-A1 (ZW)
Title: 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
Inventor: SAUL BERNARD KADIN
IPC: C07D209/70
Filed: 1985-03-18
Abstract: 2-Oxindole-1-carboxamides of the formula: 
<CHEM>
 and their pharmaceutically acceptable base-salts, where X and Y are certain optional substituents or can be taken together to form certain ring structures; and R<1> is alkyl, cycloalkyl, cycloalkenyl, optionally substituted phenyl, optionally substituted phenylalkyl, optionally substituted phenoxyalkyl, (thiophenoxy) alkyl, naphthyl, bicyclo [2.2.1]heptan-2-yl, bicyclo [2.2.1]hept-5-en-2-yl or a group of the formula -(CH2)n-Q-R<0> where n is 0, 1 or 2, Q is a divalent radical which is a specified heterocycle, and R<0> is H or alkyl. 
<??>The compounds are useful as analgesic and anti-inflammatory agents. 
<??>Also covered are certain intermediates useful in the preparation of the compounds (I), these intermediates having H in place of -COR<1>.
Patent IE-910844-A1 (IE)
Title: Base felt for roofing underfelts
Inventor: ZERFASS KARL-CHRISTIAN
IPC: D06N5/00
Filed: 1991-03-13
Abstract: The support web consists of a spunbonded material made of polyester filaments. The spunbonded material has an area weight of 50 to 100 g/m<2> with an individual filament count of 1 to 8 dtex and is fastened by a fusible binder. By means of this, a high tear propagation resistance and nail pull-out resistance and also a good dimensional stability results at high temperatures. The spunbonded material is therefore particularly suitable as a support web for bitumenised roof truss webs.
Patent MA-28104-A1 (MA)
Inventor: JENSEN MARK
IPC: C07D471/04
Filed: 2006-04-24
Abstract: An efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl} cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine and its succinate salt are provided. The succinate salt is crystalline and has superior properties.
Patent MA-41654-A1 (MA)
Title: Formes cristallines d'un inhibiteur de tyrosine kinase de bruton
Inventor: SMYTH MARK
IPC: A61P35/00
Filed: 2013-06-03
Abstract: La présente invention concerne l'inhibiteur de tyrosine kinase de bruton (btk) 1-((r)-3-(4-amino-3-(4-phénoxyphényl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)pipéridin-1-yl)prop-2-èn-1-one, celui-ci comprenant des formes cristallines, des solvates et des sels de qualité pharmaceutique de celui-ci. L'invention concerne également des compositions pharmaceutiques qui comprennent l'inhibiteur de btk, ainsi que des procédés d'utilisation de l'inhibiteur de btk, seul ou en combinaison avec d'autres agents thérapeutiques, pour le traitement de maladies ou d'états auto-immuns, de maladies ou d'états hétéro-immuns, du cancer, y compris un lymphome, et de maladies ou d'états inflammatoires.